Predictions
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€2.16
10.01.23
10.01.23
€4.00
31.12.25
31.12.25
-46.57%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.79
27.12.22
27.12.22
-
27.12.23
27.12.23
-90.75%
29.07.23
29.07.23
Capable Management
Risky Investment
No uniques
No Innovation
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€19.20
12.12.22
12.12.22
€0.000
12.12.23
12.12.23
-63.50%
15.12.22
15.12.22
Capable Management
Risky Investment
No uniques
No Innovation
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.62
14.09.22
14.09.22
-
14.09.23
14.09.23
1.70%
17.09.22
17.09.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.62
13.09.22
13.09.22
-
13.09.23
13.09.23
-37.10%
17.09.22
17.09.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.91
13.08.22
13.08.22
€1.00
13.08.23
13.08.23
-12.70%
23.08.22
23.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.77
10.06.22
10.06.22
€0.20
10.06.23
10.06.23
24.58%
26.06.22
26.06.22
Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€7.59
01.04.22
01.04.22
€12.50
01.04.23
01.04.23
-76.56%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year
Vyant Bio Inc.
Start price
Target price
Perf. (%)
€8.50
30.03.22
30.03.22
-
30.03.23
30.03.23
-24.12%
31.03.22
31.03.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.00
17.01.22
17.01.22
-
17.01.23
17.01.23
-44.67%
22.01.22
22.01.22
Risky Investment
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€30.00
04.10.21
04.10.21
-
04.10.22
04.10.22
-39.47%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€5.30
13.09.21
13.09.21
-
13.09.22
13.09.22
8.49%
19.09.21
19.09.21
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.15
09.09.21
09.09.21
€10.00
31.12.23
31.12.23
-75.78%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€52.08
13.08.21
13.08.21
€20.00
13.08.22
13.08.22
-65.13%
08.01.22
08.01.22
Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
Dynatronics Corp
Start price
Target price
Perf. (%)
€1.07
26.07.21
26.07.21
€2.50
26.07.22
26.07.22
-1.87%
07.08.21
07.08.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.12
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
14.10%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€32.25
08.02.21
08.02.21
€50.00
08.02.22
08.02.22
6.98%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year